Back
Bioventus 10K Form
Sell
42
BVS
Bioventus
Last Price:
3.98
Seasonality Move:
72.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-26 | 10K | BVS/Bioventus Annual |
Receive BVS News And Ratings
See the #1 stock for the next 7 days that we like better than BVS
BVS Financial Statistics
Sales & Book Value
| Annual Sales: | $512.35M |
|---|---|
| Cash Flow: | $10.01M |
| Price / Cash Flow: | 31.16 |
| Annual Sales: | $2.74 |
| Price / Book: | 1.46 |
Profitability
| EPS (TTM): | -2.51000 |
|---|---|
| Net Income (TTM): | $-156.23M |
| Gross Margin: | $328.19M |
| Return on Equity: | -58.58% |
| Return on Assets: | -16.55% |
Bioventus Earnings Forecast
Key Bioventus Financial Ratios
- The Gross Profit Margin over the past 9 years for BVS is 64.06%.
- The Selling, General & Administrative Expenses for BVS have been equal to 59.31% of Gross Profit Margin.
- The Research & Development expenses have been 2.62% of Revenue.
- The Interest Expense is -26.04% of Operating Income.
- The Net Earning history of BVS is -30.49% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 5 years.
Bioventus Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | BVS |
| Website: | bioventus.com |
Debt
| Debt-to-Equity Ratio: | 2.27 |
|---|---|
| Current Ratio: | 1.53 |
| Quick Ratio: | 0.91 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 10.88 |